Egetis Therapeutics AB

NEW
LTS:0ABW (Sweden)  
kr 6.15 +0.040 (+0.65%) Jul 31
At Loss
P/B:
11.26
Market Cap:
kr 2.79B ($ 292.95M)
Enterprise V:
kr 2.72B ($ 285.37M)
Volume:
7.50K
Avg Vol (2M):
16.13K
Trade In:
Volume:
7.50K
At Loss
Avg Vol (2M):
16.13K

Egetis Therapeutics AB (LTS:0ABW) Dividend

Egetis Therapeutics AB (LTS:0ABW) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -22.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LTS:0ABW Dividend

Does Egetis Therapeutics AB (LTS:0ABW) pay a dividend?

Egetis Therapeutics AB (LTS:0ABW) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Egetis Therapeutics AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Egetis Therapeutics AB has returned capital to shareholders via buybacks at a rate of -22.6% over the past 3 years.

What are dividend-paying alternatives to Egetis Therapeutics AB?

For dividend-paying alternatives in Egetis Therapeutics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.